Surveillance of pancreatic cancer patients after surgical resection

Kristin M. Sheffield, Kristen T. Crowell, Yu Li Lin, Clarisse Djukom, James Goodwin, Taylor S. Riall

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Background. There are no clear recommendations to guide posttreatment surveillance in patients with pancreatic cancer. Our goal was to describe the posttreatment surveillance patterns in patients undergoing curative-intent resection for pancreatic cancer. Methods. We used Surveillance, Epidemiology, and End Results (SEER) - Medicare linked data (1992-2005) to identify CT scans and physician visits in patientswith pancreatic cancer who underwent curative resection (n = 2393). Surveillance began 90 days after surgery, and patients were followed for 2 years at 6-month intervals. Patients were censored if they died, experienced recurrence of disease, or entered hospice. Results. A total of 2045 patients survived uncensored to the beginning of the surveillance period. CT scan use decreased from 20.9% of patients in month 4 to 6.4% in month 27. There was no temporal pattern in CT use to suggest regular surveillance. Twenty-three percent of patients did not receive a CT scan in the year after surgery, increasing to 42% the second year. Patients who underwent adjuvant therapy and patients diagnosed in later years had higher CT scan use over the surveillance periods. Most patients visited both a primary care physician and a cancer specialist in each 6-month surveillance period. Patients who visited cancer specialists were more likely to have any CT scan and to be scanned more frequently. Conclusions. Current surveillance patterns after resection for pancreatic cancer reflect the lack of established guidelines, implying a need for evaluation and standardization of surveillance protocols. The lack of a temporal pattern in CT testing suggests that most were obtained to evaluate symptoms rather than for routine surveillance.

Original languageEnglish (US)
Pages (from-to)1670-1677
Number of pages8
JournalAnnals of Surgical Oncology
Volume19
Issue number5
DOIs
StatePublished - May 2012

Fingerprint

Pancreatic Neoplasms
Hospices
Primary Care Physicians
Medicare
Ambulatory Surgical Procedures
Neoplasms
Epidemiology
Guidelines
Physicians
Recurrence

ASJC Scopus subject areas

  • Surgery
  • Oncology

Cite this

Sheffield, K. M., Crowell, K. T., Lin, Y. L., Djukom, C., Goodwin, J., & Riall, T. S. (2012). Surveillance of pancreatic cancer patients after surgical resection. Annals of Surgical Oncology, 19(5), 1670-1677. https://doi.org/10.1245/s10434-011-2152-y

Surveillance of pancreatic cancer patients after surgical resection. / Sheffield, Kristin M.; Crowell, Kristen T.; Lin, Yu Li; Djukom, Clarisse; Goodwin, James; Riall, Taylor S.

In: Annals of Surgical Oncology, Vol. 19, No. 5, 05.2012, p. 1670-1677.

Research output: Contribution to journalArticle

Sheffield, KM, Crowell, KT, Lin, YL, Djukom, C, Goodwin, J & Riall, TS 2012, 'Surveillance of pancreatic cancer patients after surgical resection', Annals of Surgical Oncology, vol. 19, no. 5, pp. 1670-1677. https://doi.org/10.1245/s10434-011-2152-y
Sheffield, Kristin M. ; Crowell, Kristen T. ; Lin, Yu Li ; Djukom, Clarisse ; Goodwin, James ; Riall, Taylor S. / Surveillance of pancreatic cancer patients after surgical resection. In: Annals of Surgical Oncology. 2012 ; Vol. 19, No. 5. pp. 1670-1677.
@article{8cd023b9a13a4ca8811094bcd5b8c2c0,
title = "Surveillance of pancreatic cancer patients after surgical resection",
abstract = "Background. There are no clear recommendations to guide posttreatment surveillance in patients with pancreatic cancer. Our goal was to describe the posttreatment surveillance patterns in patients undergoing curative-intent resection for pancreatic cancer. Methods. We used Surveillance, Epidemiology, and End Results (SEER) - Medicare linked data (1992-2005) to identify CT scans and physician visits in patientswith pancreatic cancer who underwent curative resection (n = 2393). Surveillance began 90 days after surgery, and patients were followed for 2 years at 6-month intervals. Patients were censored if they died, experienced recurrence of disease, or entered hospice. Results. A total of 2045 patients survived uncensored to the beginning of the surveillance period. CT scan use decreased from 20.9{\%} of patients in month 4 to 6.4{\%} in month 27. There was no temporal pattern in CT use to suggest regular surveillance. Twenty-three percent of patients did not receive a CT scan in the year after surgery, increasing to 42{\%} the second year. Patients who underwent adjuvant therapy and patients diagnosed in later years had higher CT scan use over the surveillance periods. Most patients visited both a primary care physician and a cancer specialist in each 6-month surveillance period. Patients who visited cancer specialists were more likely to have any CT scan and to be scanned more frequently. Conclusions. Current surveillance patterns after resection for pancreatic cancer reflect the lack of established guidelines, implying a need for evaluation and standardization of surveillance protocols. The lack of a temporal pattern in CT testing suggests that most were obtained to evaluate symptoms rather than for routine surveillance.",
author = "Sheffield, {Kristin M.} and Crowell, {Kristen T.} and Lin, {Yu Li} and Clarisse Djukom and James Goodwin and Riall, {Taylor S.}",
year = "2012",
month = "5",
doi = "10.1245/s10434-011-2152-y",
language = "English (US)",
volume = "19",
pages = "1670--1677",
journal = "Annals of Surgical Oncology",
issn = "1068-9265",
publisher = "Springer New York",
number = "5",

}

TY - JOUR

T1 - Surveillance of pancreatic cancer patients after surgical resection

AU - Sheffield, Kristin M.

AU - Crowell, Kristen T.

AU - Lin, Yu Li

AU - Djukom, Clarisse

AU - Goodwin, James

AU - Riall, Taylor S.

PY - 2012/5

Y1 - 2012/5

N2 - Background. There are no clear recommendations to guide posttreatment surveillance in patients with pancreatic cancer. Our goal was to describe the posttreatment surveillance patterns in patients undergoing curative-intent resection for pancreatic cancer. Methods. We used Surveillance, Epidemiology, and End Results (SEER) - Medicare linked data (1992-2005) to identify CT scans and physician visits in patientswith pancreatic cancer who underwent curative resection (n = 2393). Surveillance began 90 days after surgery, and patients were followed for 2 years at 6-month intervals. Patients were censored if they died, experienced recurrence of disease, or entered hospice. Results. A total of 2045 patients survived uncensored to the beginning of the surveillance period. CT scan use decreased from 20.9% of patients in month 4 to 6.4% in month 27. There was no temporal pattern in CT use to suggest regular surveillance. Twenty-three percent of patients did not receive a CT scan in the year after surgery, increasing to 42% the second year. Patients who underwent adjuvant therapy and patients diagnosed in later years had higher CT scan use over the surveillance periods. Most patients visited both a primary care physician and a cancer specialist in each 6-month surveillance period. Patients who visited cancer specialists were more likely to have any CT scan and to be scanned more frequently. Conclusions. Current surveillance patterns after resection for pancreatic cancer reflect the lack of established guidelines, implying a need for evaluation and standardization of surveillance protocols. The lack of a temporal pattern in CT testing suggests that most were obtained to evaluate symptoms rather than for routine surveillance.

AB - Background. There are no clear recommendations to guide posttreatment surveillance in patients with pancreatic cancer. Our goal was to describe the posttreatment surveillance patterns in patients undergoing curative-intent resection for pancreatic cancer. Methods. We used Surveillance, Epidemiology, and End Results (SEER) - Medicare linked data (1992-2005) to identify CT scans and physician visits in patientswith pancreatic cancer who underwent curative resection (n = 2393). Surveillance began 90 days after surgery, and patients were followed for 2 years at 6-month intervals. Patients were censored if they died, experienced recurrence of disease, or entered hospice. Results. A total of 2045 patients survived uncensored to the beginning of the surveillance period. CT scan use decreased from 20.9% of patients in month 4 to 6.4% in month 27. There was no temporal pattern in CT use to suggest regular surveillance. Twenty-three percent of patients did not receive a CT scan in the year after surgery, increasing to 42% the second year. Patients who underwent adjuvant therapy and patients diagnosed in later years had higher CT scan use over the surveillance periods. Most patients visited both a primary care physician and a cancer specialist in each 6-month surveillance period. Patients who visited cancer specialists were more likely to have any CT scan and to be scanned more frequently. Conclusions. Current surveillance patterns after resection for pancreatic cancer reflect the lack of established guidelines, implying a need for evaluation and standardization of surveillance protocols. The lack of a temporal pattern in CT testing suggests that most were obtained to evaluate symptoms rather than for routine surveillance.

UR - http://www.scopus.com/inward/record.url?scp=84862548711&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862548711&partnerID=8YFLogxK

U2 - 10.1245/s10434-011-2152-y

DO - 10.1245/s10434-011-2152-y

M3 - Article

C2 - 22143577

AN - SCOPUS:84862548711

VL - 19

SP - 1670

EP - 1677

JO - Annals of Surgical Oncology

JF - Annals of Surgical Oncology

SN - 1068-9265

IS - 5

ER -